These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 26297250

  • 21. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [Abstract] [Full Text] [Related]

  • 22. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H.
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J, Epstein JI.
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [Abstract] [Full Text] [Related]

  • 24. Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma.
    Klatte T, Anterasian C, Said JW, de Martino M, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
    J Urol; 2010 Jun; 183(6):2143-7. PubMed ID: 20399450
    [Abstract] [Full Text] [Related]

  • 25. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM.
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [Abstract] [Full Text] [Related]

  • 26. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.
    Przybycin CG, McKenney JK, Reynolds JP, Campbell S, Zhou M, Karafa MT, Magi-Galluzzi C.
    Am J Surg Pathol; 2014 Sep; 38(9):1260-5. PubMed ID: 25127094
    [Abstract] [Full Text] [Related]

  • 27. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
    Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S, CORONA Project (Collaborative Research on Renal Neoplasms Association).
    J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800
    [Abstract] [Full Text] [Related]

  • 28. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF, Katz M, Yan Y, Kibel AS, Humphrey PA.
    Cancer; 2008 Aug 01; 113(3):477-83. PubMed ID: 18484589
    [Abstract] [Full Text] [Related]

  • 29. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.
    Fukatsu A, Tsuzuki T, Sassa N, Nishikimi T, Kimura T, Majima T, Yoshino Y, Hattori R, Gotoh M.
    Am J Clin Pathol; 2013 Oct 01; 140(4):500-5. PubMed ID: 24045546
    [Abstract] [Full Text] [Related]

  • 30. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.
    BJU Int; 2012 Jul 01; 110(1):76-83. PubMed ID: 22044519
    [Abstract] [Full Text] [Related]

  • 31. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS, Shuch B, Said JW, Galliano G, Jeffries RA, Afifi AA, Castor B, Magyar C, Sadaat A, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
    J Urol; 2011 Dec 01; 186(6):2168-74. PubMed ID: 22014797
    [Abstract] [Full Text] [Related]

  • 32. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
    Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, Dahl DM, Wu S, Blute ML, Huang Y, Wu CL.
    Clin Genitourin Cancer; 2015 Oct 01; 13(5):e353-60. PubMed ID: 25998556
    [Abstract] [Full Text] [Related]

  • 33. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.
    Liu N, Gan W, Qu F, Wang Z, Zhuang W, Agizamhan S, Xu L, Yin J, Guo H, Li D.
    Am J Pathol; 2018 Apr 01; 188(4):929-936. PubMed ID: 29571325
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes.
    Simone G, Tuderti G, Ferriero M, Papalia R, Misuraca L, Minisola F, Costantini M, Mastroianni R, Sentinelli S, Guaglianone S, Gallucci M.
    Eur J Surg Oncol; 2016 Nov 01; 42(11):1744-1750. PubMed ID: 27593224
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
    Katz MD, Serrano MF, Humphrey PA, Grubb RL, Skolarus TA, Gao F, Kibel AS.
    Urol Oncol; 2011 Nov 01; 29(6):738-44. PubMed ID: 19914106
    [Abstract] [Full Text] [Related]

  • 38. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV.
    Eur Urol; 2005 Oct 01; 48(4):593-600. PubMed ID: 15964127
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.
    Histopathology; 2019 Jan 01; 74(2):284-290. PubMed ID: 30129659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.